Global Large Volume Parenteral (LVP) Sales Market Report 2021

Publisher Name :
Date: 19-Apr-2021
No. of pages: 148
Inquire Before Buying

The global Large Volume Parenteral (LVP) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Large Volume Parenteral (LVP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Soft Bag LVP

- Plastic Bottle LVP

- Glass Bottle LVP

- In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.

Segment by Application

- Basic Infusion

- Therapeutic Infusion

- Nutritious Infusion

The Large Volume Parenteral (LVP) market is analysed and market size information is provided by regions (countries). Segment by Application, the Large Volume Parenteral (LVP) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Baxter Healthcare

- Kelun Pharma

- B. Braun

- Fresenius

- Teva Pharmaceutical Industries

- Pfizer (Hospira)

- Ostuka Pharmaceutical

- CR Double-Crane

- Pisa

- Huaren

- Patheon

- Aspen Holdings

- Beximco Pharma

- Cook Pharmica

- Albert David

- PSI Ltd

- Ozon Pharmaceuticals

- BAG Healthcare

- BML Parenteral Drugs

Global Large Volume Parenteral (LVP) Sales Market Report 2021

Table of Contents
1 Large Volume Parenteral (LVP) Market Overview
1.1 Large Volume Parenteral (LVP) Product Scope
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2016 & 2021 & 2027)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Large Volume Parenteral (LVP) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Large Volume Parenteral (LVP) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Large Volume Parenteral (LVP) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Large Volume Parenteral (LVP) Price Trends (2016-2027)
2 Large Volume Parenteral (LVP) Estimates and Forecasts by Region
2.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
2.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
2.3 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.2 Europe Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.3 China Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.4 Japan Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.6 India Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
3 Global Large Volume Parenteral (LVP) Competition Landscape by Players
3.1 Global Top Large Volume Parenteral (LVP) Players by Sales (2016-2021)
3.2 Global Top Large Volume Parenteral (LVP) Players by Revenue (2016-2021)
3.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
3.4 Global Large Volume Parenteral (LVP) Average Price by Company (2016-2021)
3.5 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Large Volume Parenteral (LVP) Market Size by Type
4.1 Global Large Volume Parenteral (LVP) Historic Market Review by Type (2016-2021)
4.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
4.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2021)
4.1.3 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
4.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Type (2022-2027)
4.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Type (2022-2027)
4.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Type (2022-2027)
5 Global Large Volume Parenteral (LVP) Market Size by Application
5.1 Global Large Volume Parenteral (LVP) Historic Market Review by Application (2016-2021)
5.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
5.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2021)
5.1.3 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
5.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Application (2022-2027)
5.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Application (2022-2027)
5.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Application (2022-2027)
6 North America Large Volume Parenteral (LVP) Market Facts & Figures
6.1 North America Large Volume Parenteral (LVP) Sales by Company
6.1.1 North America Large Volume Parenteral (LVP) Sales by Company (2016-2021)
6.1.2 North America Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
6.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type
6.2.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
6.2.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
6.3 North America Large Volume Parenteral (LVP) Sales Breakdown by Application
6.3.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
6.3.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)
7 Europe Large Volume Parenteral (LVP) Market Facts & Figures
7.1 Europe Large Volume Parenteral (LVP) Sales by Company
7.1.1 Europe Large Volume Parenteral (LVP) Sales by Company (2016-2021)
7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
7.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type
7.2.1 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
7.3 Europe Large Volume Parenteral (LVP) Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Large Volume Parenteral (LVP) Market Facts & Figures
8.1 China Large Volume Parenteral (LVP) Sales by Company
8.1.1 China Large Volume Parenteral (LVP) Sales by Company (2016-2021)
8.1.2 China Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
8.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type
8.2.1 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
8.2.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
8.3 China Large Volume Parenteral (LVP) Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Large Volume Parenteral (LVP) Market Facts & Figures
9.1 Japan Large Volume Parenteral (LVP) Sales by Company
9.1.1 Japan Large Volume Parenteral (LVP) Sales by Company (2016-2021)
9.1.2 Japan Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
9.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type
9.2.1 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
9.3 Japan Large Volume Parenteral (LVP) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Large Volume Parenteral (LVP) Market Facts & Figures
10.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company
10.1.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company (2016-2021)
10.1.2 Southeast Asia Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
10.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type
10.2.1 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Large Volume Parenteral (LVP) Market Facts & Figures
11.1 India Large Volume Parenteral (LVP) Sales by Company
11.1.1 India Large Volume Parenteral (LVP) Sales by Company (2016-2021)
11.1.2 India Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
11.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type
11.2.1 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
11.2.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
11.3 India Large Volume Parenteral (LVP) Sales Breakdown by Application
11.3.1 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
11.3.2 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Large Volume Parenteral (LVP) Business
12.1 Baxter Healthcare
12.1.1 Baxter Healthcare Corporation Information
12.1.2 Baxter Healthcare Business Overview
12.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Products Offered
12.1.5 Baxter Healthcare Recent Development
12.2 Kelun Pharma
12.2.1 Kelun Pharma Corporation Information
12.2.2 Kelun Pharma Business Overview
12.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Kelun Pharma Large Volume Parenteral (LVP) Products Offered
12.2.5 Kelun Pharma Recent Development
12.3 B. Braun
12.3.1 B. Braun Corporation Information
12.3.2 B. Braun Business Overview
12.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 B. Braun Large Volume Parenteral (LVP) Products Offered
12.3.5 B. Braun Recent Development
12.4 Fresenius
12.4.1 Fresenius Corporation Information
12.4.2 Fresenius Business Overview
12.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Fresenius Large Volume Parenteral (LVP) Products Offered
12.4.5 Fresenius Recent Development
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Corporation Information
12.5.2 Teva Pharmaceutical Industries Business Overview
12.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Products Offered
12.5.5 Teva Pharmaceutical Industries Recent Development
12.6 Pfizer (Hospira)
12.6.1 Pfizer (Hospira) Corporation Information
12.6.2 Pfizer (Hospira) Business Overview
12.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Products Offered
12.6.5 Pfizer (Hospira) Recent Development
12.7 Ostuka Pharmaceutical
12.7.1 Ostuka Pharmaceutical Corporation Information
12.7.2 Ostuka Pharmaceutical Business Overview
12.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Products Offered
12.7.5 Ostuka Pharmaceutical Recent Development
12.8 CR Double-Crane
12.8.1 CR Double-Crane Corporation Information
12.8.2 CR Double-Crane Business Overview
12.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CR Double-Crane Large Volume Parenteral (LVP) Products Offered
12.8.5 CR Double-Crane Recent Development
12.9 Pisa
12.9.1 Pisa Corporation Information
12.9.2 Pisa Business Overview
12.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pisa Large Volume Parenteral (LVP) Products Offered
12.9.5 Pisa Recent Development
12.10 Huaren
12.10.1 Huaren Corporation Information
12.10.2 Huaren Business Overview
12.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Huaren Large Volume Parenteral (LVP) Products Offered
12.10.5 Huaren Recent Development
12.11 Patheon
12.11.1 Patheon Corporation Information
12.11.2 Patheon Business Overview
12.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Patheon Large Volume Parenteral (LVP) Products Offered
12.11.5 Patheon Recent Development
12.12 Aspen Holdings
12.12.1 Aspen Holdings Corporation Information
12.12.2 Aspen Holdings Business Overview
12.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Aspen Holdings Large Volume Parenteral (LVP) Products Offered
12.12.5 Aspen Holdings Recent Development
12.13 Beximco Pharma
12.13.1 Beximco Pharma Corporation Information
12.13.2 Beximco Pharma Business Overview
12.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Beximco Pharma Large Volume Parenteral (LVP) Products Offered
12.13.5 Beximco Pharma Recent Development
12.14 Cook Pharmica
12.14.1 Cook Pharmica Corporation Information
12.14.2 Cook Pharmica Business Overview
12.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cook Pharmica Large Volume Parenteral (LVP) Products Offered
12.14.5 Cook Pharmica Recent Development
12.15 Albert David
12.15.1 Albert David Corporation Information
12.15.2 Albert David Business Overview
12.15.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Albert David Large Volume Parenteral (LVP) Products Offered
12.15.5 Albert David Recent Development
12.16 PSI Ltd
12.16.1 PSI Ltd Corporation Information
12.16.2 PSI Ltd Business Overview
12.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 PSI Ltd Large Volume Parenteral (LVP) Products Offered
12.16.5 PSI Ltd Recent Development
12.17 Ozon Pharmaceuticals
12.17.1 Ozon Pharmaceuticals Corporation Information
12.17.2 Ozon Pharmaceuticals Business Overview
12.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Products Offered
12.17.5 Ozon Pharmaceuticals Recent Development
12.18 BAG Healthcare
12.18.1 BAG Healthcare Corporation Information
12.18.2 BAG Healthcare Business Overview
12.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 BAG Healthcare Large Volume Parenteral (LVP) Products Offered
12.18.5 BAG Healthcare Recent Development
12.19 BML Parenteral Drugs
12.19.1 BML Parenteral Drugs Corporation Information
12.19.2 BML Parenteral Drugs Business Overview
12.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Products Offered
12.19.5 BML Parenteral Drugs Recent Development
13 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
13.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
13.4 Large Volume Parenteral (LVP) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Large Volume Parenteral (LVP) Distributors List
14.3 Large Volume Parenteral (LVP) Customers
15 Market Dynamics
15.1 Large Volume Parenteral (LVP) Market Trends
15.2 Large Volume Parenteral (LVP) Drivers
15.3 Large Volume Parenteral (LVP) Market Challenges
15.4 Large Volume Parenteral (LVP) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Large Volume Parenteral (LVP) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Large Volume Parenteral (LVP) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Large Volume Parenteral (LVP) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Large Volume Parenteral (LVP) Sales (M Units) by Region (2016-2021)
Table 5. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Table 6. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Large Volume Parenteral (LVP) Revenue Share by Region (2016-2021)
Table 8. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Large Volume Parenteral (LVP) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Large Volume Parenteral (LVP) Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Large Volume Parenteral (LVP) Sales Share by Company (2016-2021)
Table 14. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Large Volume Parenteral (LVP) Revenue Share by Company (2016-2021)
Table 16. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
Table 17. Global Large Volume Parenteral (LVP) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites and Area Served
Table 19. Manufacturers Large Volume Parenteral (LVP) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2016-2021)
Table 22. Global Large Volume Parenteral (LVP) Sales Share by Type (2016-2021)
Table 23. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Large Volume Parenteral (LVP) Sales Share by Type (2022-2027)
Table 26. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Large Volume Parenteral (LVP) Revenue Share by Type (2022-2027)
Table 28. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2016-2021)
Table 30. Global Large Volume Parenteral (LVP) Sales Share by Application (2016-2021)
Table 31. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2022-2027)
Table 34. Global Large Volume Parenteral (LVP) Sales Share by Application (2022-2027)
Table 35. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Large Volume Parenteral (LVP) Revenue Share by Application (2022-2027)
Table 37. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 39. North America Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 40. North America Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 42. North America Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 43. North America Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 44. North America Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 45. North America Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 46. North America Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 47. North America Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 48. North America Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 49. North America Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 50. Europe Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 51. Europe Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 52. Europe Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 54. Europe Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 55. Europe Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 56. Europe Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 57. Europe Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 58. Europe Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 59. Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 60. Europe Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 61. Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 62. China Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 63. China Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 64. China Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 66. China Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 67. China Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 68. China Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 69. China Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 70. China Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 71. China Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 72. China Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 73. China Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 74. Japan Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 75. Japan Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 76. Japan Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 78. Japan Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 79. Japan Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 80. Japan Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 81. Japan Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 82. Japan Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 83. Japan Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 84. Japan Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 85. Japan Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 98. India Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 99. India Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 100. India Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 102. India Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 103. India Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 104. India Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 105. India Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 106. India Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 107. India Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 108. India Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 109. India Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 110. Baxter Healthcare Corporation Information
Table 111. Baxter Healthcare Description and Business Overview
Table 112. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Baxter Healthcare Large Volume Parenteral (LVP) Product
Table 114. Baxter Healthcare Recent Development
Table 115. Kelun Pharma Corporation Information
Table 116. Kelun Pharma Description and Business Overview
Table 117. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Kelun Pharma Large Volume Parenteral (LVP) Product
Table 119. Kelun Pharma Recent Development
Table 120. B. Braun Corporation Information
Table 121. B. Braun Description and Business Overview
Table 122. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. B. Braun Large Volume Parenteral (LVP) Product
Table 124. B. Braun Recent Development
Table 125. Fresenius Corporation Information
Table 126. Fresenius Description and Business Overview
Table 127. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Fresenius Large Volume Parenteral (LVP) Product
Table 129. Fresenius Recent Development
Table 130. Teva Pharmaceutical Industries Corporation Information
Table 131. Teva Pharmaceutical Industries Description and Business Overview
Table 132. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product
Table 134. Teva Pharmaceutical Industries Recent Development
Table 135. Pfizer (Hospira) Corporation Information
Table 136. Pfizer (Hospira) Description and Business Overview
Table 137. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Pfizer (Hospira) Large Volume Parenteral (LVP) Product
Table 139. Pfizer (Hospira) Recent Development
Table 140. Ostuka Pharmaceutical Corporation Information
Table 141. Ostuka Pharmaceutical Description and Business Overview
Table 142. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
Table 144. Ostuka Pharmaceutical Recent Development
Table 145. CR Double-Crane Corporation Information
Table 146. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. CR Double-Crane Description and Business Overview
Table 148. CR Double-Crane Large Volume Parenteral (LVP) Product
Table 149. CR Double-Crane Recent Development
Table 150. Pisa Corporation Information
Table 151. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Pisa Description and Business Overview
Table 153. Pisa Large Volume Parenteral (LVP) Product
Table 154. Pisa Recent Development
Table 155. Huaren Corporation Information
Table 156. Huaren Description and Business Overview
Table 157. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Huaren Large Volume Parenteral (LVP) Product
Table 159. Huaren Recent Development
Table 160. Patheon Corporation Information
Table 161. Patheon Description and Business Overview
Table 162. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Patheon Large Volume Parenteral (LVP) Product
Table 164. Patheon Recent Development
Table 165. Aspen Holdings Corporation Information
Table 166. Aspen Holdings Description and Business Overview
Table 167. Aspen Holdings Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Aspen Holdings Large Volume Parenteral (LVP) Product
Table 169. Aspen Holdings Recent Development
Table 170. Beximco Pharma Corporation Information
Table 171. Beximco Pharma Description and Business Overview
Table 172. Beximco Pharma Large Volume Parenteral (LVP) Sales (M U
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs